{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:57:22Z","timestamp":1785463042724,"version":"3.56.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T00:00:00Z","timestamp":1175212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T00:00:00Z","timestamp":1175212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s00277-007-0289-3","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T18:45:57Z","timestamp":1175193957000},"page":"499-508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature"],"prefix":"10.1007","volume":"86","author":[{"given":"Jaspreet S.","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Jerome D.","family":"Winegarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Tworek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,30]]},"reference":[{"key":"289_CR1","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2401878","volume":"14","author":"HG Drexler","year":"2000","unstructured":"Drexler HG, Gignac SM, von Wasielewski R et al (2000) Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 14:1533\u20131559","journal-title":"Leukemia"},{"key":"289_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/10428190400011468","volume":"46","author":"E Gudgin","year":"2005","unstructured":"Gudgin E, Rashbass J, Pulford KJ et al (2005) Primary and isolated anaplastic large cell lymphoma of the bone marrow. Leuk Lymphoma 46:461\u2013463","journal-title":"Leuk Lymphoma"},{"key":"289_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","volume":"40","author":"ME Kadin","year":"2003","unstructured":"Kadin ME, Carpenter C (2003) Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol 40:244\u2013256","journal-title":"Semin Hematol"},{"key":"289_CR4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/oxfordjournals.annonc.a059359","volume":"6","author":"M Massimino","year":"1995","unstructured":"Massimino M, Gasparini M, Giardini R (1995) Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 6:915\u2013920","journal-title":"Ann Oncol"},{"key":"289_CR5","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein H, Foss HD, Durkop H et al (2000) CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681\u20133695","journal-title":"Blood"},{"key":"289_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ajh.1102","volume":"67","author":"DD Weisenburger","year":"2001","unstructured":"Weisenburger DD, Anderson JR, Diebold J et al (2001) Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin\u2019s lymphoma classification project. Am J Hematol 67:172\u2013178","journal-title":"Am J Hematol"},{"key":"289_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.50.2.128","volume":"50","author":"D Wright","year":"1997","unstructured":"Wright D, McKeever P, Carter R (1997) Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children\u2019s Cancer Study Group. J Clin Pathol 50:128\u2013134","journal-title":"J Clin Pathol"},{"key":"289_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","volume":"66","author":"H Stein","year":"1985","unstructured":"Stein H, Mason DY, Gerdes J et al (1985) The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848\u2013858","journal-title":"Blood"},{"key":"289_CR9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1182\/blood.V72.1.234.234","volume":"72","author":"P Fischer","year":"1988","unstructured":"Fischer P, Nacheva E, Mason DY et al (1988) A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin\u2019s lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72:234\u2013240","journal-title":"Blood"},{"key":"289_CR10","first-page":"59","volume":"30","author":"M Ladanyi","year":"1997","unstructured":"Ladanyi M (1997) The NPM\/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv 30:59\u201375","journal-title":"Cancer Surv"},{"key":"289_CR11","first-page":"866","volume":"3","author":"MM Le Beau","year":"1989","unstructured":"Le Beau MM, Bitter MA, Larson RA et al (1989) The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866\u2013870","journal-title":"Leukemia"},{"key":"289_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1990.tb02560.x","volume":"74","author":"DY Mason","year":"1990","unstructured":"Mason DY, Bastard C, Rimokh R et al (1990) CD30-positive large cell lymphomas (\u2019Ki-1 lymphoma\u2019) are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161\u2013168","journal-title":"Br J Haematol"},{"key":"289_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.8122112","volume":"263","author":"SW Morris","year":"1994","unstructured":"Morris SW, Kirstein MN, Valentine MB et al (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin\u2019s lymphoma. Science 263:1281\u20131284","journal-title":"Science"},{"key":"289_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00000478-198804000-00002","volume":"12","author":"BA Agnarsson","year":"1988","unstructured":"Agnarsson BA, Kadin ME (1988) Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12:264\u2013274","journal-title":"Am J Surg Pathol"},{"key":"289_CR15","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","volume":"91","author":"D Benharroch","year":"1998","unstructured":"Benharroch D, Meguerian-Bedoyan Z, Lamant L et al (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91:2076\u20132084","journal-title":"Blood"},{"key":"289_CR16","first-page":"3591","volume":"92","author":"L Brugieres","year":"1998","unstructured":"Brugieres L, Deley MC, Pacquement H et al (1998) CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92:3591\u20133598","journal-title":"Blood"},{"key":"289_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0002-9440(10)65629-5","volume":"153","author":"B Falini","year":"1998","unstructured":"Falini B, Bigerna B, Fizzotti M et al (1998) ALK expression defines a distinct group of T\/null lymphomas (\u201cALK lymphomas\u201d) with a wide morphological spectrum. Am J Pathol 153:875\u2013886","journal-title":"Am J Pathol"},{"key":"289_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/mpo.1176","volume":"37","author":"M Massimino","year":"2001","unstructured":"Massimino M, Spreafico F, Luksch R et al (2001) Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL). Med Pediatr Oncol 37:97\u2013102","journal-title":"Med Pediatr Oncol"},{"key":"289_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2141.2003.04249.x","volume":"121","author":"T Mori","year":"2003","unstructured":"Mori T, Kiyokawa N, Shimada H et al (2003) Anaplastic large cell lymphoma in Japanese children: retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development. Br J Haematol 121:94\u201396","journal-title":"Br J Haematol"},{"key":"289_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/00000478-199712000-00004","volume":"21","author":"S Nakamura","year":"1997","unstructured":"Nakamura S, Shiota M, Nakagawa A et al (1997) Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM\/ALK) expression. Am J Surg Pathol 21:1420\u20131432","journal-title":"Am J Surg Pathol"},{"key":"289_CR21","first-page":"343","volume":"151","author":"S Pittaluga","year":"1997","unstructured":"Pittaluga S, Wlodarska I, Pulford K et al (1997) The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23\/ALK rearrangements. Am J Pathol 151:343\u2013351","journal-title":"Am J Pathol"},{"key":"289_CR22","first-page":"271","volume":"115","author":"K Pulford","year":"2005","unstructured":"Pulford K, Roberton HM, Jones M (2005) Antibody techniques used in the study of anaplastic lymphoma kinase-positive ALCL. Methods Mol Med 115:271\u2013294","journal-title":"Methods Mol Med"},{"key":"289_CR23","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","volume":"86","author":"M Shiota","year":"1995","unstructured":"Shiota M, Nakamura S, Ichinohasama R et al (1995) Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity. Blood 86:1954\u20131960","journal-title":"Blood"},{"key":"289_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1046\/j.1365-2141.2001.02896.x","volume":"114","author":"B Falini","year":"2001","unstructured":"Falini B (2001) Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114:741\u2013760","journal-title":"Br J Haematol"},{"key":"289_CR25","first-page":"77","volume":"30","author":"ME Kadin","year":"1997","unstructured":"Kadin ME (1997) Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 30:77\u201386","journal-title":"Cancer Surv"},{"issue":"Suppl 1","key":"289_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/annonc\/5.suppl_1.S25","volume":"5","author":"ME Kadin","year":"1994","unstructured":"Kadin ME (1994) Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 5(Suppl 1):25\u201330","journal-title":"Ann Oncol"},{"key":"289_CR27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.1991.9.4.539","volume":"9","author":"JP Greer","year":"1991","unstructured":"Greer JP, Kinney MC, Collins RD et al (1991) Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539\u2013547","journal-title":"J Clin Oncol"},{"key":"289_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","volume":"17","author":"MC Kinney","year":"1993","unstructured":"Kinney MC, Collins RD, Greer JP et al (1993) A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 17:859\u2013868","journal-title":"Am J Surg Pathol"},{"issue":"Pt 1","key":"289_CR29","first-page":"1","volume":"26","author":"MC Kinney","year":"1991","unstructured":"Kinney MC, Greer JP, Glick AD et al (1991) Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications. Pathol Annu 26(Pt 1):1\u201324","journal-title":"Pathol Annu"},{"key":"289_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/mpo.2950220302","volume":"22","author":"H Rubie","year":"1994","unstructured":"Rubie H, Gladieff L, Robert A et al (1994) Childhood anaplastic large cell lymphoma Ki-1\/CD30: clinicopathologic features of 19 cases. Med Pediatr Oncol 22:155\u2013161","journal-title":"Med Pediatr Oncol"},{"key":"289_CR31","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0046-8177(96)90290-7","volume":"27","author":"MM Anderson","year":"1996","unstructured":"Anderson MM, Ross CW, Singleton TP et al (1996) Ki-1 anaplastic large cell lymphoma with a prominent leukemic phase. Hum Pathol 27:1093\u20131095","journal-title":"Hum Pathol"},{"key":"289_CR32","first-page":"S56","volume":"111","author":"MC Kinney","year":"1999","unstructured":"Kinney MC, Kadin ME (1999) The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol 111:S56\u2013S67","journal-title":"Am J Clin Pathol"},{"key":"289_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1046\/j.1365-2141.2001.02574.x","volume":"113","author":"SW Morris","year":"2001","unstructured":"Morris SW, Xue L, Ma Z et al (2001) Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin\u2019s lymphoma. Br J Haematol 113:275\u2013295","journal-title":"Br J Haematol"},{"key":"289_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00313020120083269","volume":"33","author":"W Cheuk","year":"2001","unstructured":"Cheuk W, Chan JK (2001) Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence. Pathology 33:7\u201312","journal-title":"Pathology"},{"key":"289_CR35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","volume":"93","author":"RD Gascoyne","year":"1999","unstructured":"Gascoyne RD, Aoun P, Wu D et al (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 93:3913\u20133921","journal-title":"Blood"},{"key":"289_CR36","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood.V86.5.1694.bloodjournal8651694","volume":"86","author":"H Herbst","year":"1995","unstructured":"Herbst H, Anagnostopoulos J, Heinze B et al (1995) ALK gene products in anaplastic large cell lymphomas and Hodgkin\u2019s disease. Blood 86:1694\u20131700","journal-title":"Blood"},{"key":"289_CR37","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0002-9440(10)65421-1","volume":"154","author":"K Pulford","year":"1999","unstructured":"Pulford K, Falini B, Cordell J et al (1999) Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. Am J Pathol 154:1657\u20131663","journal-title":"Am J Pathol"},{"key":"289_CR38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/00313020310001602594","volume":"35","author":"YC Tai","year":"2003","unstructured":"Tai YC, Kim LH, Peh SC (2003) Common ALK gene rearrangement in Asian CD30+ anaplastic large cell lymphoma: an immunohistochemical and fluorescence in situ hybridisation (FISH) study on paraffin-embedded tissue. Pathology 35:436\u2013443","journal-title":"Pathology"},{"key":"289_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/mpo.2950210603","volume":"21","author":"V Vecchi","year":"1993","unstructured":"Vecchi V, Burnelli R, Pileri S et al (1993) Anaplastic large cell lymphoma (Ki-1+\/CD30+) in childhood. Med Pediatr Oncol 21:402\u2013410","journal-title":"Med Pediatr Oncol"},{"key":"289_CR40","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/MCB.17.4.2312","volume":"17","author":"D Bischof","year":"1997","unstructured":"Bischof D, Pulford K, Mason DY et al (1997) Role of the nucleophosmin (NPM) portion of the non-Hodgkin\u2019s lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312\u20132325","journal-title":"Mol Cell Biol"},{"key":"289_CR41","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/S0301-472X(99)00116-2","volume":"27","author":"G Hubinger","year":"1999","unstructured":"Hubinger G, Scheffrahn I, Muller E et al (1999) The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation. Exp Hematol 27:1796\u20131805","journal-title":"Exp Hematol"},{"key":"289_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<132::AID-MPO7>3.0.CO;2-L","volume":"28","author":"C Kaplinsky","year":"1997","unstructured":"Kaplinsky C, Toren A, Neumann Y et al (1997) Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma. Med Pediatr Oncol 28:132\u2013135","journal-title":"Med Pediatr Oncol"},{"key":"289_CR43","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","volume":"97","author":"K Seidemann","year":"2001","unstructured":"Seidemann K, Tiemann M, Schrappe M et al (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin\u2013Frankfurt\u2013Munster Group Trial NHL-BFM 90. Blood 97:3699\u20133706","journal-title":"Blood"},{"key":"289_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/jcp.53.6.445","volume":"53","author":"RL ten Berge","year":"2000","unstructured":"ten Berge RL, Oudejans JJ, Ossenkoppele GJ et al (2000) ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol 53:445\u2013450","journal-title":"J Clin Pathol"},{"key":"289_CR45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1046\/j.1365-2141.2002.03482.x","volume":"117","author":"DM Williams","year":"2002","unstructured":"Williams DM, Hobson R, Imeson J et al (2002) Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children\u2019s Cancer Study Group chemotherapy regimens. Br J Haematol 117:812\u2013820","journal-title":"Br J Haematol"},{"key":"289_CR46","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1046\/j.1365-2141.1999.01238.x","volume":"104","author":"C Bayle","year":"1999","unstructured":"Bayle C, Charpentier A, Duchayne E et al (1999) Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases. Br J Haematol 104:680\u2013688","journal-title":"Br J Haematol"},{"key":"289_CR47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/103.1.82","volume":"103","author":"M Fraga","year":"1995","unstructured":"Fraga M, Brousset P, Schlaifer D et al (1995) Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 103:82\u201389","journal-title":"Am J Clin Pathol"},{"key":"289_CR48","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0046-8177(99)90253-8","volume":"30","author":"I Abdulkader","year":"1999","unstructured":"Abdulkader I, Cameselle-Teijeiro J, Fraga M et al (1999) Primary anaplastic large cell lymphoma of the central nervous system. Hum Pathol 30:978\u2013981","journal-title":"Hum Pathol"},{"key":"289_CR49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/pbc.20250","volume":"44","author":"G Armstrong","year":"2005","unstructured":"Armstrong G, Szallasi A, Biegel JA et al (2005) Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literature. Pediatr Blood Cancer 44:400\u2013406","journal-title":"Pediatr Blood Cancer"},{"key":"289_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000028731","volume":"29","author":"N Buxton","year":"1998","unstructured":"Buxton N, Punt J, Hewitt M (1998) Primary Ki-1-positive T-cell lymphoma of the brain in a child. Pediatr Neurosurg 29:250\u2013252","journal-title":"Pediatr Neurosurg"},{"key":"289_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00000478-200304000-00008","volume":"27","author":"DH George","year":"2003","unstructured":"George DH, Scheithauer BW, Aker FV et al (2003) Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression. Am J Surg Pathol 27:487\u2013493","journal-title":"Am J Surg Pathol"},{"key":"289_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0090-3019(96)00033-X","volume":"46","author":"R Goldbrunner","year":"1996","unstructured":"Goldbrunner R, Warmuth-Metz M, Tonn JC et al (1996) Primary Ki-1-positive T-cell lymphoma of the brain\u2013an aggressive subtype of lymphoma: case report and review of the literature. Surg Neurol 46:37\u201341","journal-title":"Surg Neurol"},{"key":"289_CR53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ajcp\/103.4.496","volume":"103","author":"N Havlioglu","year":"1995","unstructured":"Havlioglu N, Manepalli A, Galindo L et al (1995) Primary Ki-1 (anaplastic large cell) lymphoma of the brain and spinal cord. Am J Clin Pathol 103:496\u2013499","journal-title":"Am J Clin Pathol"},{"key":"289_CR54","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1054\/jocn.2000.0854","volume":"8","author":"T Kawamura","year":"2001","unstructured":"Kawamura T, Inamura T, Ikezaki K et al (2001) Primary Ki-1 lymphoma in the central nervous system. J Clin Neurosci 8:574\u2013577","journal-title":"J Clin Neurosci"},{"key":"289_CR55","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/1042819031000103999","volume":"44","author":"CN Lin","year":"2003","unstructured":"Lin CN, Hou CC, Hwang WS et al (2003) Anaplastic large cell lymphoma\u2014a rare disorder in southern Taiwan. Leuk Lymphoma 44:1727\u20131731","journal-title":"Leuk Lymphoma"},{"key":"289_CR56","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00043426-200312000-00014","volume":"25","author":"T Mori","year":"2003","unstructured":"Mori T, Sugita K, Kimura K et al (2003) Isolated central nervous system (CNS) relapse in a case of childhood systemic anaplastic large cell lymphoma without initial CNS involvement. J Pediatr Hematol Oncol 25:975\u2013977","journal-title":"J Pediatr Hematol Oncol"},{"key":"289_CR57","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/annonc\/mdf300","volume":"13","author":"M Ponzoni","year":"2002","unstructured":"Ponzoni M, Terreni MR, Ciceri F et al (2002) Primary brain CD30+ ALK1+ anaplastic large cell lymphoma (\u2018ALKoma\u2019): the first case with a combination of \u2018not common\u2019 variants. Ann Oncol 13:1827\u20131832","journal-title":"Ann Oncol"},{"key":"289_CR58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1200\/JCO.1994.12.5.899","volume":"12","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Tiemann M et al (1994) Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin\u2013Frankfurt\u2013Munster group studies. J Clin Oncol 12:899\u2013908","journal-title":"J Clin Oncol"},{"key":"289_CR59","first-page":"326","volume":"51","author":"A Rupani","year":"2005","unstructured":"Rupani A, Modi C, Desai S et al (2005) Primary anaplastic large cell lymphoma of central nervous system\u2014a case report. J Postgrad Med 51:326\u2013327","journal-title":"J Postgrad Med"},{"key":"289_CR60","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ajh.10059","volume":"69","author":"N Awaya","year":"2002","unstructured":"Awaya N, Mori S, Takeuchi H et al (2002) CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma. Am J Hematol 69:200\u2013204","journal-title":"Am J Hematol"},{"key":"289_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00000478-199901000-00005","volume":"23","author":"KB Hodges","year":"1999","unstructured":"Hodges KB, Collins RD, Greer JP et al (1999) Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features. Am J Surg Pathol 23:49\u201358","journal-title":"Am J Surg Pathol"},{"key":"289_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cancergencyto.2004.03.004","volume":"154","author":"SY Kong","year":"2004","unstructured":"Kong SY, Cho HJ, Suk JH et al (2004) A novel complex t(2;5;13)(p23;q35;q14) in small cell variant type anaplastic large cell lymphoma with peripheral involvement. Cancer Genet Cytogenet 154:183\u2013185","journal-title":"Cancer Genet Cytogenet"},{"key":"289_CR63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-2257.2000.00144.x","volume":"22","author":"JF Lesesve","year":"2000","unstructured":"Lesesve JF, Buisine J, Gregoire MJ et al (2000) Leukaemic small cell variant anaplastic large cell lymphoma during pregnancy. Clin Lab Haematol 22:297\u2013301","journal-title":"Clin Lab Haematol"},{"key":"289_CR64","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1309\/WH8P-NU9P-K4RR-V852","volume":"120","author":"M Onciu","year":"2003","unstructured":"Onciu M, Behm FG, Raimondi SC et al (2003) ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature. Am J Clin Pathol 120:617\u2013625","journal-title":"Am J Clin Pathol"},{"key":"289_CR65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/02841869609098508","volume":"35","author":"A Toren","year":"1996","unstructured":"Toren A, Neumann Y, Rosner E et al (1996) Pediatric small cell variant of Ki-1 (CD30) + T-cell lymphoma with germ-line configuration of the T-cell receptor gene. Acta Oncol 35:243\u2013245","journal-title":"Acta Oncol"},{"key":"289_CR66","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s002770050603","volume":"78","author":"N Villamor","year":"1999","unstructured":"Villamor N, Rozman M, Esteve J et al (1999) Anaplastic large-cell lymphoma with rapid evolution to leukemic phase. Ann Hematol 78:478\u2013482","journal-title":"Ann Hematol"},{"key":"289_CR67","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y et al (2005) Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Cancer 103:2091\u20132098","journal-title":"Cancer"},{"issue":"Suppl 1","key":"289_CR68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/annonc\/5.suppl_1.S31","volume":"5","author":"SB Murphy","year":"1994","unstructured":"Murphy SB (1994) Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood. Ann Oncol 5(Suppl 1):31\u201333","journal-title":"Ann Oncol"},{"key":"289_CR69","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/cncr.21438","volume":"104","author":"A Rosolen","year":"2005","unstructured":"Rosolen A, Pillon M, Garaventa A et al (2005) Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer 104:2133\u20132140","journal-title":"Cancer"},{"key":"289_CR70","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2141.2005.05478.x","volume":"129","author":"R Sonnen","year":"2005","unstructured":"Sonnen R, Schmidt WP, Muller-Hermelink HK et al (2005) The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 129:366\u2013372","journal-title":"Br J Haematol"},{"key":"289_CR71","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1365-2559.2003.01726.x","volume":"43","author":"RL ten Berge","year":"2003","unstructured":"ten Berge RL, de Bruin PC, Oudejans JJ et al (2003) ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology 43:462\u2013469","journal-title":"Histopathology"},{"key":"289_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1309\/J9R2-72ED-50G4-JW5F","volume":"125","author":"NA Bakshi","year":"2006","unstructured":"Bakshi NA, Ross CW, Finn WG et al (2006) ALK-positive anaplastic large cell lymphoma with primary bone involvement in children. Am J Clin Pathol 125:57\u201363","journal-title":"Am J Clin Pathol"},{"key":"289_CR73","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell SM, Habermann TM, Kurtin PJ et al (1997) Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 15:2296\u20132301","journal-title":"J Clin Oncol"},{"key":"289_CR74","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jcp.10472","volume":"199","author":"K Pulford","year":"2004","unstructured":"Pulford K, Morris SW, Turturro F (2004) Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 199:330\u2013358","journal-title":"J Cell Physiol"},{"key":"289_CR75","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood.V96.6.2172","volume":"96","author":"R Suzuki","year":"2000","unstructured":"Suzuki R, Kagami Y, Takeuchi K et al (2000) Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype. Blood 96:2993\u20133000","journal-title":"Blood"},{"key":"289_CR76","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V93.8.2688","volume":"93","author":"RL ten Berge","year":"1999","unstructured":"ten Berge RL, Dukers DF, Oudejans JJ et al (1999) Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma. Blood 93:2688\u20132696","journal-title":"Blood"},{"key":"289_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/A:1008352726155","volume":"11","author":"L Brugieres","year":"2000","unstructured":"Brugieres L, Quartier P, Le Deley MC et al (2000) Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children\u2014a report from the French Society of Pediatric Oncology. Ann Oncol 11:53\u201358","journal-title":"Ann Oncol"},{"key":"289_CR78","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2141.2000.02098.x","volume":"109","author":"E Deconinck","year":"2000","unstructured":"Deconinck E, Lamy T, Foussard C et al (2000) Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial. Br J Haematol 109:736\u2013742","journal-title":"Br J Haematol"},{"key":"289_CR79","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ijc.21410","volume":"118","author":"K Ait-Tahar","year":"2006","unstructured":"Ait-Tahar K, Cerundolo V, Banham AH et al (2006) B and CTL responses to the ALK protein in patients with ALK-positive ALCL. Int J Cancer 118:688\u2013695","journal-title":"Int J Cancer"},{"key":"289_CR80","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1034\/j.1600-0609.2003.00144.x","volume":"71","author":"B Borisch","year":"2003","unstructured":"Borisch B, Yerly S, Cerato C et al (2003) ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions. Eur J Haematol 71:243\u2013249","journal-title":"Eur J Haematol"},{"key":"289_CR81","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood-2003-04-1038","volume":"103","author":"D Cussac","year":"2004","unstructured":"Cussac D, Greenland C, Roche S et al (2004) Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood 103:1464\u20131471","journal-title":"Blood"},{"key":"289_CR82","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0301-472X(01)00688-9","volume":"29","author":"M Ergin","year":"2001","unstructured":"Ergin M, Denning MF, Izban KF et al (2001) Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein. Exp Hematol 29:1082\u20131090","journal-title":"Exp Hematol"},{"key":"289_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","volume":"85","author":"B Falini","year":"1995","unstructured":"Falini B, Pileri S, Pizzolo G et al (1995) CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1\u201314","journal-title":"Blood"},{"key":"289_CR84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/annonc\/13s50046","volume":"13","author":"C Hatton","year":"2002","unstructured":"Hatton C, Roberton H, Banham AH et al (2002) Persistence of antibody response to ALK proteins in patients with ALK-lymphoma. Annals of Oncology 13:46","journal-title":"Annals of Oncology"},{"key":"289_CR85","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/00001622-200011000-00012","volume":"12","author":"HB Koon","year":"2000","unstructured":"Koon HB, Junghans RP (2000) Anti-CD30 antibody-based therapy. Curr Opin Oncol 12:588\u2013593","journal-title":"Curr Opin Oncol"},{"key":"289_CR86","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1080\/1042819031000099625","volume":"44","author":"L Passoni","year":"2003","unstructured":"Passoni L, Gambacorti-Passerini C (2003) ALK a novel lymphoma-associated tumor antigen for vaccination strategies. Leuk Lymphoma 44:1675\u20131681","journal-title":"Leuk Lymphoma"},{"key":"289_CR87","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1182\/blood.V96.4.1605","volume":"96","author":"K Pulford","year":"2000","unstructured":"Pulford K, Falini B, Banham AH et al (2000) Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. Blood 96:1605\u20131607","journal-title":"Blood"},{"key":"289_CR88","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2141.1995.tb05586.x","volume":"90","author":"S Sforzini","year":"1995","unstructured":"Sforzini S, Bolognesi A, Meazza R et al (1995) Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti-CD30\/anti-gelonin bispecific antibodies. Br J Haematol 90:572\u2013577","journal-title":"Br J Haematol"},{"key":"289_CR89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1992.tb08208.x","volume":"81","author":"PL Tazzari","year":"1992","unstructured":"Tazzari PL, Bolognesi A, de Totero D et al (1992) Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin\u2019s disease and CD30+ lymphoma: in vitro evaluation. Br J Haematol 81:203\u2013211","journal-title":"Br J Haematol"},{"key":"289_CR90","first-page":"988","volume":"84","author":"PL Tazzari","year":"1999","unstructured":"Tazzari PL, de Totero D, Bolognesi A et al (1999) An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. Haematologica 84:988\u2013995","journal-title":"Haematologica"},{"key":"289_CR91","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1046\/j.1365-2141.1995.404942.x","volume":"92","author":"A Terenzi","year":"1996","unstructured":"Terenzi A, Bolognesi A, Pasqualucci L et al (1996) Anti-CD30(BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Br J Haematol 92:872\u2013879","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-007-0289-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0289-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:21:36Z","timestamp":1683786096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-007-0289-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,30]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0289-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,30]]},"assertion":[{"value":"12 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}